These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8166571)

  • 21. CAPD peritonitis and fluoroquinolones: a review.
    Janknegt R
    Perit Dial Int; 1991; 11(1):48, 53-8. PubMed ID: 2049423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The adverse effects of fluoroquinolones.
    Smith CR
    J Antimicrob Chemother; 1987 Jun; 19(6):709-11. PubMed ID: 3475267
    [No Abstract]   [Full Text] [Related]  

  • 23. [Activity of fluoroquinolones studied on a model of suppurative meningoencephalitis caused by Pseudomonas aeruginosa in mice].
    Padeĭskaia EN; Mnatsakanian VE
    Antibiot Khimioter; 1991 Jul; 36(7):25-8. PubMed ID: 1953184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative pharmacokinetics of ciprofloxacin, ofloxacin and pefloxacin in human aqueous humour.
    Giamarellou H; Kanellas D; Kavouklis E; Petrikkos G; Gabriel L
    Eur J Clin Microbiol Infect Dis; 1993 Apr; 12(4):293-7. PubMed ID: 8513819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of enoxacin, ofloxacin, and norfloxacin concentration in human benign prostatic tissue].
    Yasumoto R; Asakawa M
    Hinyokika Kiyo; 1988 Aug; 34(8):1519-21. PubMed ID: 3195414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
    Renaudin H; Quentin C; de Barbeyrac B; Bebear C
    Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative penetration of lomefloxacin and other quinolones into human phagocytes.
    Perea EJ; García I; Pascual A
    Am J Med; 1992 Apr; 92(4A):48S-51S. PubMed ID: 1316071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinolone penetration into canine vaginal and urethral secretions.
    Gasser TC; Graversen PH; Larsen EH; Dørflinger T
    Scand J Urol Nephrol Suppl; 1987; 104():101-5. PubMed ID: 3481457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics of fluoroquinolones in patients with renal insufficiency].
    Iakovlev SV; Iakovlev VP; Izotova GN
    Antibiot Khimioter; 1995 Oct; 40(10):39-47. PubMed ID: 8660120
    [No Abstract]   [Full Text] [Related]  

  • 30. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).
    Alestig K
    Scand J Infect Dis Suppl; 1990; 68():19-22. PubMed ID: 2218417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ciprofloxacin and norfloxacin pharmacokinetics and prostatic fluid penetration in dogs after multiple oral dosing.
    Albarellos GA; Montoya L; Waxman S; Kreil V; Ambros LA; Hallu R; Rebuelto M
    Vet J; 2006 Sep; 172(2):334-9. PubMed ID: 15994101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluoroquinolones as pneumococcal therapy: closing the barn door before the horse escapes.
    Tillotson G; Zhao X; Drlica K
    Lancet Infect Dis; 2001 Oct; 1(3):145-6. PubMed ID: 11871490
    [No Abstract]   [Full Text] [Related]  

  • 34. Residues of fluoroquinolone drugs in the cloacal gland and other tissues of Japanese quail.
    Mohan J; Sastry KV; Tyagi JS; Rao GS; Singh RV
    Br Poult Sci; 2006 Feb; 47(1):83-7. PubMed ID: 16546801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fluoroquinolones--antibacterial activity, pharmacokinetics and indications for a new group of chemotherapeutic drugs].
    Naumann P; Dopp C
    Internist (Berl); 1989 Jan; 30(1):20-31. PubMed ID: 2646237
    [No Abstract]   [Full Text] [Related]  

  • 36. Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (Macaca fascicularis).
    Hummler H; Richter WF; Hendrickx AG
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):34-45. PubMed ID: 8397453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of ferrous sulphate on the absorption of norfloxacin, ciprofloxacin and ofloxacin.
    Lehto P; Kivistö KT; Neuvonen PJ
    Br J Clin Pharmacol; 1994 Jan; 37(1):82-5. PubMed ID: 8148225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacokinetics and tissue penetration of the fluoroquinolones.
    Bergeron MG
    Clin Invest Med; 1989 Feb; 12(1):20-7. PubMed ID: 2920479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Penetration of pefloxacin and its desmethyl metabolite into the uroepithelium after a 800-mg single oral dose in human patients.
    Moreau JL; Royer-Morrot MJ; Lozniewski A; Trackoen G; Delavault P; Royer RJ
    Eur J Clin Pharmacol; 1996; 49(5):401-5. PubMed ID: 8866637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aqueous and vitreous penetration of topically applied ciprofloxacin and ofloxacin.
    Taustine LR
    J Cataract Refract Surg; 2004 Jan; 30(1):6. PubMed ID: 14967251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.